Issue Date | Title | Author(s) |
2015 | Chemical enhancement of fingerprints on various porous and non-porous surfaces | Magro, Louise; Shoemake, Claire; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2017 | Compilation, validation and evaluation of a 2d/3d molecular database as an adjunct to didactic teaching modalities | Sultana, G.; Shoemake, Claire; Camilleri, Liberato |
2013 | Creating a high-throughput screening database to propose ligands capable of modulating the HIV-1 protease receptor | Micallef, Chantelle; Shoemake, Claire; Azzopardi, Lilian M. |
2013-08 | Creation of a 2D and 3D molecular database using drugs used in obstetric, gynaecological and urinary tract infections | Ellul, Mariana; Shoemake, Claire; Azzopardi, Lilian M. |
2015-10-01 | Crude fibre determination of Malva sylvestris L. and evaluation of its faecal bulking and laxative properties in rats | Busuttil-Griffin, Francesca; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M. |
2015 | The design and optimisation of novel human dihydrofolate reductase inhibitors for the management of proliferative disease | Portelli, Graziella; Shoemake, Claire |
2016 | Design and optimisation of novel Huperzine A analogues capable of modulating the acetylcholinesterase receptor for the management of Alzheimer’s disease | Bonavia, Sara; Shoemake, Claire |
2017 | Design and optimization of K-Ras protein inhibitors as anticancer agents using deltarasin as a case study | Woods, Martina; Shoemake, Claire |
2017 | Design of novel compounds with the potential of dual PPARγ/α modulation for the management of metabolic syndrome | Ellul, Claire; Shoemake, Claire |
2013-08 | Drug design of de novo designed molecules at the peroxisome proliferator activated receptor | Portelli, Stephanie; Shoemake, Claire; Azzopardi, Lilian M. |
2013-08 | Drug design of molecules binding to the 5-HT receptor using a bioisosteric approach | Schembri, Maria; Shoemake, Claire; Azzopardi, Lilian M. |
2014 | Drug design of novel molecules using a bioisosteric and de novo techniques - a comparison | Schembri, Maria; Shoemake, Claire; Sant Fournier, Marianne |
2014-05-27 | The effects of Anabasine and the alkaloid extract of Nicotiana glauca on Lepidopterous Larvae | Zammit, Michelle; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M. |
2016 | Evaluation and Optimization of In Silico Designed PDE4B Modulators | Attard, Daniel; Shoemake, Claire; Vella, John; Żmudzki, Paweł; Chłoń-Rzepa, Grażyna; Wyska, Elżbieta |
2017 | Evaluation and optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 modulators for the management of multiple sclerosis | Gusman, Daphne H.; Shoemake, Claire |
2016 | Evaluation and optimization of in silico designed β-Secretase modulators for the treatment of "Alzheimer's Disease" | Borg, Luke; Xuereb, Keith; Shoemake, Claire |
2013-08 | Evaluation of a molecular database of drugs used to target the endocrine system | Borg, Denise; Shoemake, Claire; Azzopardi, Lilian M. |
2015 | Generating a homology model of the human M1 muscarinic receptor and the design of cognate modulators at this locus for the management of Alzheimer’s disease | Bugeja, Neil J.; Shoemake, Claire |
2016-07 | Identification of lead molecules capable of the simultaneous agonism of the PPARƴ and PPARα subtypes for the dual management of diabetes mellitus and dyslipidaemia | Ellul, Claire; Shoemake, Claire |
2014 | In silico identification of a potentially novel binding modality for 1,3-dicarbonyl compounds having 2(3h)-benzazolonic heterocycles within the pparγ ligand binding pocket : a de novo design study | Portelli, Stephanie; Shoemake, Claire; Azzopardi, Lilian M. |
2009-11 | Investigating the angiotensin converting enzyme (ACE) inhibiting properties of naturally occurring terpenes using in silico models | Mifsud, S. J.; Shoemake, Claire; Attard, Everaldo; Sant Fournier, Marianne; Azzopardi, Lilian M. |
2013 | Investigating the anti-oestrogenic effect of p-Synephrine and de novo design of oestrogen receptor modulating molecules | Pace Bardon, C.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
2013-02-28 | Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico models | Farrugia, Deborah Louise; Shoemake, Claire; Attard, Everaldo; Azzopardi, Lilian M.; Mifsud, S. J. |
2013 | Labelling and testing of foods designated as suitable for diabetic and low calorie diets | Cordina, Jakov; Shoemake, Claire; Azzopardi, Lilian M. |
2013 | De novo design of non-steroidal oestrogen receptor modulating molecules using maltanedienol as a lead molecule | Shoemake, Claire; Azzopardi, Lilian M.; Saliba, Charles; Gutierrez, Gilles; Cassar, Maria |
2012 | Optimisation of abiraterone based non-steroidal lead molecules | Grima, A.; Shoemake, Claire; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
2012 | Optimisation of Tyrosine-based lead molecules capable of Modulation of the Peroxisome Proliferator-Activated Receptor Gamma | Ciantar, J.; Shoemake, Claire; Mangani, C.; Azzopardi, Lilian M.; Serracino-Inglott, Anthony |
2016 | Optimization of in silico designed fatty acid synthase modulators derived from the lead molecule orlistat | Shoemake, Claire; Sciberras, R. |
2015 | A structure-based drug design approach for the identification of novel selective Cyclooxygenase-2 inhibitors using resveratrol analogues as lead molecules | Caruana, Clarissa; Shoemake, Claire |